Regencell Bioscience Holdings Limited
RGC
株式のランク
#3315
Regencell Bioscience Holdings Limited is a biotechnology firm specializing in... Regencell Bioscience Holdings Limited is a biotechnology firm specializing in Traditional Chinese Medicine (TCM). Its core activities revolve around the research, development, and market introduction of TCM solutions specifically designed to address neurocognitive disorders and related degeneration. The company places a particular emphasis on conditions such as attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). Established in 2014, Regencell Bioscience maintains its primary office in Causeway Bay, Hong Kong.
株価
$9.80
時価総額
$4.86B
変化（1日）
-9.24%
変化（1年）
-37.77%
国
HK
取引 Regencell Bioscience Holdings Limited (RGC)
カテゴリー
Healthcare
Regencell Bioscience Holdings Limited（RGC）の株価履歴
終値の最高値: $8.34 （2026-10-01）
終値の最安値: $0.24 （2021-07-01）
終値の最安値: $0.24 （2021-07-01）
Regencell Bioscience Holdings Limited の株価履歴（2021 ～ 2026）
年間株価パフォーマンス
| 年 | パフォーマンス |
|---|---|
| 2026 (TTM) | -1.78% |
| 2025 | 13,046.47% |
| 2024 | -47.20% |
| 2023 | -66.01% |
| 2022 | 8.50% |
| 2021 | 0.00% |
類似企業または競合の株価
| 企業 | 株価 | 変化率 1年% | 国 |
|---|---|---|---|
| $171.67 | - |
DE
|
|
| $165.31 | 23.62% |
DE
|
|
| $40.45 | 43.11% |
JP
|
|
| $224.81 | 31.28% |
CH
|
|
| $18.43 | -4.03% |
IN
|
